UNIONDALE, NY / ACCESS Newswire / December 30, 2025 / Marquis Who's Who honors Lakia Lewis-Latin, MBA, for her excellence in pharmaceutical access, patient support innovation and reimbursement ...
MedPage Today on MSNOpinion
I Was Wrong About RFK Jr.
Kennedy Jr. to a broken clock: even he might stumble onto the right answer a couple times a day. As part of our review of the ...
Sustaining progress in the development of lifesaving cancer therapies will require aligning policy with science, advancing value-based care, and strengthening collaboration to ensure technologies ...
Gene Hackman, star of “'Hoosiers,” died at his Santa Fe home in February. The actor was 95 and beloved by Hoosiers for his ...
The global Aronia Berries Market is estimated to be valued at USD 381.8 million in 2025 and is projected to reach USD 533.4 ...
The European Union customized premix industry is entering a sustained growth phase, supported by structural shifts in food ...
Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...
Rocket Pharmaceuticals is a Buy, with strong catalysts, undervalued programs, and significant upside. Click here to read my ...
U.S. News reaches out to business schools to supply first year compensation for over hundred schools Better still, The ...
Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback